EGFR and malignant colon neoplasm: We also found that rTBL-1 retains its cytotoxic apoptosis-inducing effect on colon cancer cells via influencing epidermal growth factor cell receptor (EGFR) signaling pathways and principally by causing partial receptor degradation and activation of p38 MAPK signaling [15].